The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Prognostic Factors Associated with Survival in Patients with Primary Duodenal Adenocarcinoma

  • Chung, Woo-Chul (Department of Internal Medicine, The Catholic University of Korea School of Medicine) ;
  • Paik, Chang-Nyol (Department of Internal Medicine, The Catholic University of Korea School of Medicine) ;
  • Jung, Sung-Hoon (Department of Internal Medicine, The Catholic University of Korea School of Medicine) ;
  • Lee, Kang-Moon (Department of Internal Medicine, The Catholic University of Korea School of Medicine) ;
  • Kim, Sang-Woo (Department of Internal Medicine, The Catholic University of Korea School of Medicine) ;
  • Chang, U-Im (Department of Internal Medicine, The Catholic University of Korea School of Medicine) ;
  • Yang, Jin-Mo (Department of Internal Medicine, The Catholic University of Korea School of Medicine)
  • Published : 2011.03.01
⟨ Previous Next ⟩

Abstract

Background/Aims: The prognostic factors in primary duodenal adenocarcinoma remain controversial. This study evaluated the prognostic factors associated with survival in patients with primary duodenal adenocarcinoma. Methods: From March 1996 to June 2008, the medical records of 30 patients with a final diagnosis of primary duodenal epithelial malignancy seen at two referral centers were reviewed retrospectively. The prognostic factors for survival were evaluated 6 months and 1, 2, and 5 years after the diagnosis. Results: The median survival was 5.7 months. The survival rate was 46.7% (14/30), 16.7% (5/30), 10% (3/30), and 6.7% (2/30) at 6 months and 1, 2, and 5 years, respectively. Multivariate analysis showed that cancer-directed treatment, including curative surgery or chemotherapy, was a common independent risk factor at all follow-up times. Total bilirubin, cytology, and TNM stage were independent risk factors for survival at 1, 2, and 5 years. The white blood cell count was an independent risk factor at 1 year only. The actuarial probability of survival in patients undergoing cancer-directed treatment was significantly higher than in those without treatment at 6 months (71.4 vs. 25.0%, p < 0.01), 1 year (28.6 vs. 6.3%, p < 0.01), 2 years (21.4 vs. 0%, p < 0.01), and 5 years (14.3 vs. 0%, p < 0.01). Conclusions: The prognostic factors in patients with primary duodenal adenocarcinoma were total bilirubin, TNM stage, cytology, and cancer-directed treatments until the 5-year follow-up. Especially, cancer-directed treatments improved patient survival.

Keywords

References

  1. Spira IA, Ghazi A, Wolff WI. Primary adenocarcinoma of the duodenum. Cancer 1977;39:1721-1726. https://doi.org/10.1002/1097-0142(197704)39:4<1721::AID-CNCR2820390450>3.0.CO;2-M
  2. Bucher P, Gervaz P, Morel P. Long-term results of radical resection for locally advanced duodenal adenocarcinoma. Hepatogastroenterology 2005;52:1727-1729.
  3. Lillemoe K, Imbembo AL. Malignant neoplasms of the duodenum. Surg Gynecol Obstet 1980;150:822-826.
  4. Moss WM, McCart PM, Juler G, Miller DR. Primary adenocarcinoma of the duodenum. Arch Surg 1974;108:805-807. https://doi.org/10.1001/archsurg.1974.01350300047013
  5. Pitt HA. Duodenal cancer: endoscopic or surgical resection? J Clin Gastroenterol 2003;37:356-357. https://doi.org/10.1097/00004836-200311000-00002
  6. Rose DM, Hochwald SN, Klimstra DS, Brennan MF. Primary duodenal adenocarcinoma: a ten-year experience with 79 patients. J Am Coll Surg 1996;183:89-96.
  7. Hung FC, Kuo CM, Chuah SK, et al. Clinical analysis of primary duodenal adenocarcinoma: an 11-year experience. J Gastroenterol Hepatol 2007;22:724-728. https://doi.org/10.1111/j.1440-1746.2007.04935.x
  8. Bal A, Joshi K, Vaiphei K, Wig JD. Primary duodenal neoplasms: a retrospective clinico-pathological analysis. World J Gastroenterol 2007;13:1108-1111. https://doi.org/10.3748/wjg.v13.i7.1108
  9. Lee CC, Ng WK, Lin KW, Lai TW, Li SM. Adenocarcinoma of the duodenum. Hong Kong Med J 2008;14:67-69.
  10. Gonzalez GD, Evans EC. Primary adenocarcinoma of the duodenum. Am Surg 1987;53:174-179.
  11. Agrawal S, McCarron EC, Gibbs JF, Nava HR, Wilding GE, Rajput A. Surgical management and outcome in primary adenocarcinoma of the small bowel. Ann Surg Oncol 2007;14:2263-2269. https://doi.org/10.1245/s10434-007-9428-2
  12. Bakaeen FG, Murr MM, Sarr MG, et al. What prognostic factors are important in duodenal adenocarcinoma? Arch Surg 2000;135:635-641. https://doi.org/10.1001/archsurg.135.6.635
  13. Hu JX, Miao XY, Zhong DW, Dai WD, Liu W, Hu W. Surgical treatment of primary duodenal adenocarcinoma. Hepatogastroenterology 2006;53:858-862.
  14. Sohn TA, Lillemoe KD, Cameron JL, et al. Adenocarcinoma of the duodenum: factors influencing long-term survival. J Gastrointest Surg 1998;2:79-87. https://doi.org/10.1016/S1091-255X(98)80107-8
  15. Barnes G Jr, Romero L, Hess KR, Curley SA. Primary adenocarcinoma of the duodenum: management and survival in 67 patients. Ann Surg Oncol 1994;1:73-78. https://doi.org/10.1007/BF02303544
  16. Lee HG, You DD, Paik KY, Heo JS, Choi SH, Choi DW. Prognostic factors for primary duodenal adenocarcinoma. World J Surg 2008;32:2246-2252. https://doi.org/10.1007/s00268-008-9678-6
  17. Rotman N, Pezet D, Fagniez PL, Cherqui D, Celicout B, Lointier P. Adenocarcinoma of the duodenum: factors influencing survival. French Association for Surgical Research. Br J Surg 1994;81:83-85. https://doi.org/10.1002/bjs.1800810128
  18. Sexe RB, Wade TP, Virgo KS, Johnson FE. Incidence and treatment of periampullary duodenal cancer in the U.S. veteran patient population. Cancer 1996;77:251-254. https://doi.org/10.1002/(SICI)1097-0142(19960115)77:2<251::AID-CNCR5>3.0.CO;2-P
  19. Santoro E, Sacchi M, Scutari F, Carboni F, Graziano F. Primary adenocarcinoma of the duodenum: treatment and survival in 89 patients. Hepatogastroenterology 1997;44:1157-1163.
  20. Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 2004;101:518-526. https://doi.org/10.1002/cncr.20404
  21. Brucher BL, Stein HJ, Roder JD, et al. New aspects of prognostic factors in adenocarcinomas of the small bowel. Hepatogastroenterology 2001;48:727-732.
  22. Stell D, Mayer D, Mirza D, Buckels J. Delayed diagnosis and lower resection rate of adenocarcinoma of the distal duodenum. Dig Surg 2004;21:434-438. https://doi.org/10.1159/000083470
  23. Locher C, Malka D, Boige V, et al. Combination chemotherapy in advanced small bowel adenocarcinoma. Oncology 2005;69:290-294. https://doi.org/10.1159/000089678

Cited by

  1. Adenocarcinoma of the third duodenal portion: Case report and review of literature vol.4, pp.1, 2011, https://doi.org/10.4240/wjgs.v4.i1.23
  2. Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma vol.398, pp.2, 2013, https://doi.org/10.1007/s00423-012-0978-9
  3. Defining the Role of Adjuvant Therapy: Ampullary and Duodenal Adenocarcinoma vol.24, pp.2, 2011, https://doi.org/10.1016/j.semradonc.2013.11.001
  4. Primary Non-ampullary Duodenal Adenocarcinoma: A Single-center Experience for 15 Years vol.66, pp.4, 2015, https://doi.org/10.4166/kjg.2015.66.4.194
  5. A Resected Case of Mucinous Adenocarcinoma of the Duodenum, Mimicking Intraductal Papillary Neoplasm of the Bile Duct vol.100, pp.11, 2011, https://doi.org/10.9738/intsurg-d-15-00001.1
  6. Duodenal Adenocarcinoma: Profile and Predictors of Survival Outcomes vol.81, pp.11, 2011, https://doi.org/10.1177/000313481508101124
  7. Prognosis and nomogram for predicting postoperative survival of duodenal adenocarcinoma: A retrospective study in China and the SEER database vol.8, pp.None, 2011, https://doi.org/10.1038/s41598-018-26145-6
  8. Simple Versus Radical Resection for Duodenal Adenocarcinoma: A Propensity Score Matched Analysis of National Cancer Database vol.87, pp.2, 2011, https://doi.org/10.1177/0003134820951432
  9. Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysis vol.26, pp.3, 2021, https://doi.org/10.1007/s10147-020-01840-5